There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
Levothyroxine, which is authorised for the control of an underactive thyroid, and is now available in strengths of 12.5mcg and 75mcg tablets, Teva...
Clinical predictions for the year ahead New medicines and guidance The increasing age of the population brings with it a rise in the number of...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter